<DOC>
	<DOCNO>NCT02543827</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety biological vaccine ( MV140 ) woman Recurrent Urinary Tract Infections ( RUTI ) compare placebo group .</brief_summary>
	<brief_title>Evaluation Efficacy Safety MV140</brief_title>
	<detailed_description>Double blind parallel placebo control study . The subject receive medication three six month follow another twelve month .</detailed_description>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Urologic Diseases</mesh_term>
	<criteria>Gave write informed consent . Women Aged 18 75 year . They must able meet dose regimen . Individuals least 3 episode cystitis past 12 month . Subject respond health hygiene measure and/or suppressive treatment and/or postcoital prophylaxis . Not grant informed write consent . Not include establish age range . Not offer cooperation I serious psychiatric disorder . Present pathological postvoiding residue . Submit moderadagrave incontinence . Present genital tumor . Suffering urinary tract tumor . Submit lithiasis . Present alteration immune system .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Recurrent Urinary Tract Infections ( RUTI )</keyword>
	<keyword>Female Urogenital Diseases Pregnancy Complications</keyword>
</DOC>